(Total Views: 553)
Posted On: 09/24/2024 1:00:10 PM
Post# of 154361
Add this ST post to today news of:
" Leronlimab monotherapy (700 mg) demonstrated statistically significant fibrosis reversal compared to an isotype IgG4 control arm (p<0.01);"
Good ST post that lists IgG4 diseases.
I'm not a member & can't scroll back far enough.
But the disease list does not look to be of Madrigal interest.
So....2 different partnerships?
Dr. J pointed out #1 for a reason.
Shall see....
" Leronlimab monotherapy (700 mg) demonstrated statistically significant fibrosis reversal compared to an isotype IgG4 control arm (p<0.01);"
Good ST post that lists IgG4 diseases.
I'm not a member & can't scroll back far enough.
But the disease list does not look to be of Madrigal interest.
So....2 different partnerships?
Dr. J pointed out #1 for a reason.
Shall see....
(2)
(0)
